Recursion and PathAI offer cutting-edge AI solutions in healthcare, focusing on drug discovery and pathology, respectively. Recursion stands out with innovative recursive observation and multi-agent orchestration, while PathAI is favored for its FDA-cleared AISight® Dx platform and strong integration with healthcare systems. With notable differences in company size (~800 for Recursion vs. ~280 for PathAI) and funding ($1.2B for PathAI), these tools cater to different aspects of healthcare AI applications.
Best for
PathAI is the better choice when needing a robust, FDA-cleared pathology solution with comprehensive integrations into lab and clinical systems, benefiting teams focused on diagnostic accuracy and patient outcomes.
Best for
Recursion is the better choice when seeking an open-source platform to manage complex AI tasks in drug discovery with a focus on scalability and integration with modern cloud tools like TensorFlow and Kubernetes.
Key Differences
Verdict
Choose Recursion if you are focused on AI-driven drug discovery with a need for customizable and open-source solutions. Opt for PathAI if your priority is AI-enabled pathology with regulatory-backed assurances and extensive healthcare system integrations. Each tool excels in its respective domain, making the decision reliant on specific business needs and regulatory considerations.
PathAI
At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clini
There are no direct user reviews or social mentions focused on "PathAI" in the information provided. However, if "PathAI" were part of a similar context, user reviews might focus on its capabilities in enhancing AI accuracy and streamlining diagnostic processes as strengths, while potential complaints could revolve around integration issues or pricing. The sentiment surrounding pricing might be sensitive for niche AI tools, generally reflecting an expectation for value relative to high costs. Overall, a tool like PathAI often holds a reputable position in the specialized AI sector for its innovative contributions.
Recursion
Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us
User reviews and social mentions about "Recursion" mainly highlight its innovative approach to AI with unique features such as recursive observation and multi-agent orchestration. The main strength noted is the tool's ability to manage complex AI tasks efficiently through these recursive methodologies. However, some users express skepticism about its ability to compete with well-established solutions, particularly concerning AI consciousness and vulnerabilities. Pricing sentiment is not explicitly mentioned, but the tool's open-source nature suggests a positive reception. Overall, Recursion has a reputation for being a cutting-edge, open-source platform with a niche following among tech enthusiasts and developers.
PathAI
+32% vs last weekRecursion
Stable week-over-weekPathAI
Recursion
PathAI
Recursion
PathAI
Recursion
PathAI (8)
Recursion (1)
Only in PathAI (5)
Only in Recursion (10)
Only in PathAI (15)
Only in Recursion (8)
PathAI
Recursion
PathAI
Recursion
PathAI
No YouTube channel
Recursion
AI’s Current Proof Points in Drug Discovery – and the Next Frontier
Mar 26, 2026
Highlights from Recursion's Evening of Hope Event for Rare Disease Day 2026
Mar 24, 2026
An Evening of Hope: 2026 Rare Disease Day Event at Recursion
Mar 23, 2026
Recursion's Era of Value Realization: CFO Ben Taylor at Leerink Global Healthcare Conference
Mar 18, 2026
PathAI
No screenshots
Recursion
PathAI
Recursion
PathAI
100 Tips & Tricks for Building Your Own Personal AI Agent /LONG POST/
*Everything I learned the hard way — 6 weeks, no sleep :), two environments, one agent that actually works.* # The Story I spent six weeks building a personal AI agent from scratch — not a chatbot wrapper, but a persistent assistant that manages tasks, tracks deals, reads emails, analyzes business
Recursion
Only in Recursion (2)
Recursion is better for drug discovery applications, while PathAI excels in pathology-related diagnostic processes.
Recursion, being open-source, may offer more flexible pricing, whereas PathAI's FDA-cleared platform likely involves higher licensing fees.
Recursion, with its tech-savvy user base and open-source nature, might offer more community-driven support compared to PathAI.
While both tools serve different niches, integration might be limited; however, indirect collaboration can enhance comprehensive healthcare AI strategies.
Recursion may be easier to start with due to its open-source community resources, while PathAI might require more specialized knowledge for setup.
